Code: MTA2809 | Publication Date: Mar 2025 |
The Middle East Vaccines Market has witnessed steady growth over the years, driven by increasing awareness of infectious disease prevention and the advancement of healthcare systems. This progress has encouraged numerous pharmaceutical companies to establish a presence in the region, addressing the rising demand for vaccines. Leading vaccine manufacturers, with decades of service in the Middle East, have significantly enhanced public health by supplying essential vaccines and investing heavily in research and development. These companies, with their diverse product portfolios and unwavering commitment to innovation and quality, continue to shape the region's healthcare landscape. As the need for safe and effective vaccines escalates, their role in meeting healthcare requirements becomes increasingly vital. Recognizing and supporting their efforts is essential to ensuring vaccine accessibility for all segments of the population.
In collaboration with government initiatives and the dedication of healthcare professionals, these companies are pivotal in promoting public health and curbing the spread of diseases in the region. Their expertise and investment in developing life-saving vaccines for both existing and emerging health challenges foster hope for a healthier future in the Middle East. Acknowledging their contributions and encouraging ongoing innovation through sustained support and collaboration will further strengthen the region's healthcare infrastructure. These collective efforts are instrumental in improving public health outcomes, ensuring a resilient and healthier future for the people of the Middle East. As per 6Wresearch, Middle East Vaccines Market is projected to grow at a significant CAGR of 9.2% from 2025 - 2031F.
Company Name | GlaxoSmithKline Pharmaceuticals Ltd. |
---|---|
Headquarters | London, United Kingdom |
Established Year | 1924 |
Official Website | Click Here |
GlaxoSmithKline (GSK) Pharmaceuticals Ltd. has been serving the Middle East region for over 90 years, providing innovative and high-quality vaccines to combat infectious diseases. Some of their popular vaccines in this market include Synflorix, Rotarix, Menveo, and Bexsero. GSK also has a strong focus on research and development, constantly striving to improve existing vaccines and develop new ones to meet the changing needs of the region.
Company Name | Pfizer Inc. |
---|---|
Headquarters | New York, United States |
Established Year | 1849 |
Official Website | Click Here |
Pfizer Inc. is well-known for its contribution to the development of one of the most successful COVID-19 vaccines, along with other important vaccinations such as Prevnar 13, Trumenba, and Typhim Vi. In the Middle East region, Pfizer has been operating for more than six decades and is committed to providing innovative and accessible vaccines for the prevention of life-threatening diseases.
Company Name | Sanofi Pasteur |
---|---|
Headquarters | Paris, France |
Established Year | 1974 |
Official Website | Click Here |
Sanofi Pasteur has a long-standing presence in the Middle East market, offering a wide range of vaccines for the prevention of various infectious diseases such as diphtheria, tetanus, pertussis, polio, influenza, and more. The company also invests significantly in research and development, aiming to enhance the effectiveness and safety of their existing vaccines and develop new ones.
Company Name | Merck & Co., Inc. |
---|---|
Headquarters | New Jersey, United States |
Established Year | 1891 |
Official Website | Click Here |
Merck & Co., Inc. has been operating in the Middle East region for over a century, providing life-saving vaccines such as Gardasil, M-M-R II, Varivax, ProQuad, Pneumovax 23, among others. The company is committed to improving public health in the region through its diverse portfolio of vaccines and medicines, along with investing in research and development for breakthrough treatments.
Company Name | Novartis International AG |
---|---|
Headquarters | Basel, Switzerland |
Established Year | 1996 |
Official Website | Click Here |
Novartis has been operating in the Middle East since the late 1940s, catering to the growing demand for vaccines and medicines. Some of their popular vaccines in this market include Menveo, Bexsero, Cervarix, Agrippal, and Fluad. The company has a strong commitment to research and development, continuously working towards improving existing vaccines and developing new ones.
Company Name | Johnson & Johnson |
---|---|
Headquarters | New Jersey, United States |
Established Year | 1886 |
Official Website | Click Here |
Johnson & Johnson has been operating in the Middle East for over 90 years, providing essential vaccines such as Stamaril, Adacel, Menveo, Bexsero, among others. The company also focuses on research and development to develop new and innovative vaccines to address the region's healthcare needs.
Company Name | AstraZeneca |
---|---|
Headquarters | Cambridge, United Kingdom |
Established Year | 1999 |
Official Website | Click Here |
AstraZeneca has been serving the Middle East market for over two decades, offering important vaccines such as Menveo, Fluenz Tetra, Zinplava, Brilinta, among others. The company is committed to investing in research and development to improve existing vaccines and develop new ones that can make a positive impact on public health in the region.
Company Name | Sinopharm Group Co., Ltd. |
---|---|
Headquarters | Beijing, China |
Established Year | 1998 |
Official Website | Click Here |
Sinopharm Group has been operating in the Middle East for over two decades, offering essential vaccines such as Inactivated SARS-CoV-2 Vaccine, Varicella Vaccine Live (SAID®), Rabies Vaccine (Vero Cell) for human use, and more. The company also has a strong research and development team that continuously works towards improving the efficacy and safety of their vaccines.
Company Name | Bharat Biotech |
---|---|
Headquarters | Hyderabad, India |
Established Year | 1996 |
Official Website | Click Here |
Bharat Biotech has been operating in the Middle East for over two decades, offering essential vaccines such as Rotavac, Typbar-TCV, Revac-B+ Tetanus Vaccine (human), among others. The company is committed to investing in research and development to improve existing vaccines and develop new ones that can address the region's healthcare needs.
Company Name | Biological E. Limited |
---|---|
Headquarters | Hyderabad, India |
Established Year | 1953 |
Official Website | Click Here |
Biological E. Limited has been operating in the Middle East for over two decades, offering essential vaccines such as Rotavac, Vibrio Cholerae Bivalent Vaccine Oral Suspension (vaccine), Human Rabies Immunoglobulin (human), among others. The company is committed to providing high-quality vaccines at an affordable price to meet the region's healthcare needs. They also invest in research and development to develop new vaccines for various diseases.